Skip to content

TELE-CONNECT: Telehealth Exercise for Continence After Gynaecological Cancer Treatment

Telehealth-delivered exercise to treat incontinence in women following gynaecological cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622000580774
Acronym
TELE-CONNECT
Enrollment
78
Registered
2022-04-20
Start date
2022-10-13
Completion date
2024-08-23
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study (called TELE-CONNECT) is a telehealth program to deliver pelvic floor muscle training to women with gynaecological cancer who suffer from urinary incontinence. Urinary incontinence affects around one-third of women causing signifcant physical, social, emotional and financial burden. The prevalence of incontinence is doubled in women with gynaecological cancer. Although evidence supports pelvic floor muscle training as first-line treatment for urinary incontinence, it is not known whether this treatment is as effective for women following gynaecological cancer treatment. This will be the first randomised trial to address this vital clinical question using the novel method of telehealth. Who is it for? You may be eligible for this study if you are an adult female following cancer treatment (with and without radiotherapy) for Stage I, II or III uterine, cervical, fallopian tube, primary peritoneal or ovarian cancer or borderline ovarian tumour. Study details: Participants who consent to be contacted by the research team will receive a phone call to determine their eligibility. Those who are suitable for the study and consent to participate will complete a baseline assessment and record any bladder leakage experienced over a 7-day period using an ‘Accident Diary’. They will then be asked to participate in one of two different treatment groups 1) usual care or 2) pelvic floor physiotherapy delivered via video-calls. Each participant is put into a group by chance (randomly) using a computer program. Participants in both groups will be sent high quality bladder and bowel advice handouts. Group 1 will receive one, 15-minute telephone call with a female member of the research team. Group 2 will receive an intensive, supervised, 16-week telehealth-delivered pelvic floor muscle training program (including 8 video-consultations) from a female, qualified and experienced physiotherapist. They will also receive their own pelvic floor muscle biofeedback device. All participants will complete questionnaires at the end of 17 and 52 weeks from the commencement of the study. It is hoped that this research trial will demonstrate that a 16-week, physiotherapist-supervised, telehealth-delivered pelvic floor muscle training program can reduce urinary incontinence compared with usual care, in women following gynaecological cancer treatment.

Interventions

Pelvic floor muscle training (PFMT) + home exercise program + non-exercise components. Pelvic floor muscle training (PFMT) intervention: 'What' The intervention: 8 x 30-60 minute telehealth sessions over 16 weeks (e.g. at 1, 2, 4, 6, 8, 10, 13 & 16 weeks). The initial consultation will be 60 minutes, consultations 2 - 7 will be 30 minutes and consultation 8 will be 45 minutes in order to provide all elements of the intervention at the appropriate time. 'Who' The provider: Physiotherapist with p

Pelvic floor muscle training (PFMT) + home exercise program + non-exercise components. Pelvic floor muscle training (PFMT) intervention: 'What' The intervention: 8 x 30-60 minute telehealth sessions over 16 weeks (e.g. at 1, 2, 4, 6, 8, 10, 13 & 16 weeks). The initial consultation will be 60 minutes, consultations 2 - 7 will be 30 minutes and consultation 8 will be 45 minutes in order to provide all elements of the intervention at the appropriate time. 'Who' The provider: Physiotherapist with postgraduate training in pelvic floor physiotherapy. Per-protocol study training: detailed study manual and training in study processes and procedures, designed specifically for this study, including: pelvic floor muscle (PFM) assessment and exercise instruction processes; instructions for teaching use of the biofeedback device (device name: 'femfit®'); biofeedback data export; practice video-consultations to practice video-consultation skills. In the 8 weeks before the first participant is enrolled, physiotherapists will undergo protocol training, using live face to face and online training, supplemented by supply of all required resources and standard operating protocols. During the study: regular meetings with the research team to review per-protocol procedures to ensure adherence to standardised training protocols. 'How' Group or individual: Individual telehealth-delivered instruction in PFMT. The woman will receive the telehealth and home exercise program in her home. The femfit’s® pre-determined, starting level and exercise program will be used. The starting level may be modified and additional tailoring to each woman may also be recommended by the treating study physiotherapist based on assessment findings. Supervision: Individually-supervised remotely via telehealth. Between telehealth consultations women will complete their PFMT unsupervised, 5 days per week. After randomisation and before their first telehealth consultation each intervention group participant will receive by registered post a participant study manual that will include: - a welcome letter describing their involvement in the study and listing all study resources that they will have received - detailed instructions of how to use the telehealth Zoom Cloud Meetings software (Zoom) for physiotherapy consultations - information regarding good bladder and bowel health (same as control group) and participant diaries (e.g. exercise and accident diaries) - detailed instructions of how to use the femfit® biofeedback device and associated smartphone app - a femfit® biofeedback device to help teach the correct PFM contraction technique, to monitor PFM strength gains during telehealth consultations and home practice, and facilitate PFMT adherence - prior to participant's first physiotherapy consultation, a member of the research team will schedule a Zoom consultation with the participant, to ensure they are able to connect successfully for their physiotherapy consultations. Adherence to exercise measures: Adherence to PFMT will be recorded within the femfit® app. The participant can elect to have daily reminders sent ('pushed') to her phone to remind her to do her exercises once a day at a time selected by the participant; this setting is available in the app. Attendance at physiotherapy consultations will be recorded by the physiotherapist. Motivation strategies: Biofeedback will be provided via the femfit® device and associated app. Biofeedback is provided to the participant via a visual display of the pressure profile created by the participant's pelvic floor muscle contraction, relative to a target pressure line that the participant aims to match. This pressure profile is only visible to the participant when she is performing her pelvic floor muscle exercises using the sensor and the app. In addition, physiotherapists will draw from an extensive list of behaviour change motivational strategies according to the woman's needs. Example strategies may include goal setting, specific instructions/wording on how to perform PFMT, verbal persuasion, visual cues. Progression: The femfit’s ® pre-determined, exercise program and recommended progressions will be used which are evidence-based and clinically validated. Within the femfit® app the intensity and repetitions of the exercises increase every 4 weeks. In the first month, the exercise program will take around 8 minutes to complete daily. This increases to 12 minutes in the second month, 16 minutes in months 3 and 4. The participant will then enter a maintenance phase with exercises performed 3 times per week until 52 weeks. The position to do the exercises also changes from lying to supported standing, to standing. Detailed description of exercise session: PFM exercises included in the femfit ® training program are: maximal contraction, co-ordination, endurance, contraction with cough. These will be described in the femfit® app as “Squeeze”, “Rapid”, “Enduro”, and “Knack”. Home program: PFM exercises, as prescribed by the physiotherapist, will be conducted by the woman at her home. Specific home exercise details regarding position, time, dosage, effort and use of the femfit® app will be provided by the physiotherapist at each consultation. Non-exercise components: Intervention participants will receive the same informational handouts regarding good bladder and bowel health as the usual care group. Additional information will be provided as indicated: - For urinary urgency and frequency or urge urinary incontinence: bladder training including urinary urge suppression techniques, education on fluid intake modification including caffeine reduction if relevant, and education in good bladder and bowel habits. - For faecal incontinence: bowel routine training, education on dietary fibre including psyllium supplementation, education on faecal urgency suppression techniques.

Sponsors

The University of Melbourne
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Women aged 18 years or more; following cancer treatment (with or without radiotherapy) for Stage I, II or III uterine, cervical, fallopian tube, primary peritoneal or ovarian cancer or borderline ovarian tumour; have the ability to speak and read English sufficiently for purposes of the study; have primary cancer treatment completed at least 6 months ago or adjuvant therapy completed at least 3 months ago; have self-reported urinary incontinence (at least 1 episode per week for last 4 weeks); have not received (in clinic or telehealth) >1 physiotherapy-supervised pelvic floor treatment session for urinary incontinence since commencing cancer treatment OR in the previous 4 years (whichever is most recent); and have a home internet connection and a smartphone.

Exclusion criteria

Women who are pregnant or breastfeeding; have given birth within the last 12 months; have a severe pelvic organ prolapse; have a vaginal pessary ring in situ; have a significant neurological disorder; have a severe physical or psychiatric impairment; unable to participate in the e-health components of the study; have had pelvic surgery for incontinence or pelvic organ prolapse in the last 2 years; are not willing to use an intra-vaginal biofeedback device or videoconferencing software (Zoom or other) or are unable to give informed consent or complete all study and assessment procedures.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 6, 2026